▶ 調査レポート

δ-バレロラクトンのグローバル市場 2021年:企業別、地域別、種類・用途別

• 英文タイトル:Global δ-Valerolactone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。δ-バレロラクトンのグローバル市場 2021年:企業別、地域別、種類・用途別 / Global δ-Valerolactone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-203B04779資料のイメージです。• レポートコード:GIR-203B04779
• 出版社/出版日:GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
δ-バレロラクトン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のδ-バレロラクトンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx%の変化があります。世界のδ-バレロラクトンの市場規模は次の5年間でxxx%のCAGRで成長すると予想されます。

δ-バレロラクトン市場は種類と用途によって区分されます。2016年~2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・アッセイ:98%、アッセイ:99%

用途別セグメントは次のように区分されます。
・コーティング剤、接着剤、樹脂添加剤、医薬品&農薬中間体

世界のδ-バレロラクトン市場の主要な市場プレーヤーは以下のとおりです。
・BASF、Ube Industries、MYJ Chemical、Ningbo INNO Pharmchem、Skylead Pharmaceuticals & Chemicals、Penta Manufacturing、Zhejiang Boadge Chemical

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計14章あります。
・第1章では、δ-バレロラクトン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なδ-バレロラクトンメーカーの企業概要、2019年~2021年までのδ-バレロラクトンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なδ-バレロラクトンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年~2026年までの地域別δ-バレロラクトンの販売量、売上、成長性を示しています。
・第5、6章では、2016年~2026年までのδ-バレロラクトンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年~2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年~2026年までの主要地域でのδ-バレロラクトン市場予測を収録しています。
・第12、13、14章では、δ-バレロラクトンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):BASF、Ube Industries、MYJ Chemical、Ningbo INNO Pharmchem、Skylead Pharmaceuticals & Chemicals、Penta Manufacturing、Zhejiang Boadge Chemical
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:アッセイ:98%、アッセイ:99%
・用途別分析2016年-2026年:コーティング剤、接着剤、樹脂添加剤、医薬品&農薬中間体
・δ-バレロラクトンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・δ-バレロラクトンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・δ-バレロラクトンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・δ-バレロラクトンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・δ-バレロラクトンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The δ-Valerolactone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global δ-Valerolactone size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global δ-Valerolactone market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
δ-Valerolactone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Assay: 98%
Assay: 99%

Market segment by Application can be divided into
Coatings, Adhesives, Resin Additives
Pharmaceutical and Agrochemical Intermediates

The key market players for global δ-Valerolactone market are listed below:
BASF
Ube Industries
MYJ Chemical
Ningbo INNO Pharmchem
Skylead Pharmaceuticals & Chemicals
Penta Manufacturing
Zhejiang Boadge Chemical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe δ-Valerolactone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of δ-Valerolactone, with price, sales, revenue and global market share of δ-Valerolactone from 2019 to 2021.
Chapter 3, the δ-Valerolactone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the δ-Valerolactone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and δ-Valerolactone market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe δ-Valerolactone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 δ-Valerolactone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global δ-Valerolactone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Assay: 98%
1.2.3 Assay: 99%
1.3 Market Analysis by Application
1.3.1 Overview: Global δ-Valerolactone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Coatings, Adhesives, Resin Additives
1.3.3 Pharmaceutical and Agrochemical Intermediates
1.4 Global δ-Valerolactone Market Size & Forecast
1.4.1 Global δ-Valerolactone Sales in Value (2016-2026))
1.4.2 Global δ-Valerolactone Sales in Volume (2016-2026)
1.4.3 Global δ-Valerolactone Price by Type (2016-2026) & (US$/MT)
1.5 Global δ-Valerolactone Production Capacity Analysis
1.5.1 Global δ-Valerolactone Total Production Capacity (2016-2026)
1.5.2 Global δ-Valerolactone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 δ-Valerolactone Market Drivers
1.6.2 δ-Valerolactone Market Restraints
1.6.3 δ-Valerolactone Trends Analysis
2 Manufacturers Profiles
2.1 BASF
2.1.1 BASF Details
2.1.2 BASF Major Business
2.1.3 BASF δ-Valerolactone Product and Services
2.1.4 BASF δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Ube Industries
2.2.1 Ube Industries Details
2.2.2 Ube Industries Major Business
2.2.3 Ube Industries δ-Valerolactone Product and Services
2.2.4 Ube Industries δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 MYJ Chemical
2.3.1 MYJ Chemical Details
2.3.2 MYJ Chemical Major Business
2.3.3 MYJ Chemical δ-Valerolactone Product and Services
2.3.4 MYJ Chemical δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Ningbo INNO Pharmchem
2.4.1 Ningbo INNO Pharmchem Details
2.4.2 Ningbo INNO Pharmchem Major Business
2.4.3 Ningbo INNO Pharmchem δ-Valerolactone Product and Services
2.4.4 Ningbo INNO Pharmchem δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Skylead Pharmaceuticals & Chemicals
2.5.1 Skylead Pharmaceuticals & Chemicals Details
2.5.2 Skylead Pharmaceuticals & Chemicals Major Business
2.5.3 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Product and Services
2.5.4 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Penta Manufacturing
2.6.1 Penta Manufacturing Details
2.6.2 Penta Manufacturing Major Business
2.6.3 Penta Manufacturing δ-Valerolactone Product and Services
2.6.4 Penta Manufacturing δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Zhejiang Boadge Chemical
2.7.1 Zhejiang Boadge Chemical Details
2.7.2 Zhejiang Boadge Chemical Major Business
2.7.3 Zhejiang Boadge Chemical δ-Valerolactone Product and Services
2.7.4 Zhejiang Boadge Chemical δ-Valerolactone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 δ-Valerolactone Sales by Manufacturer
3.1 Global δ-Valerolactone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global δ-Valerolactone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in δ-Valerolactone
3.4 Market Concentration Rate
3.4.1 Top 3 δ-Valerolactone Manufacturer Market Share
3.4.2 Top 6 δ-Valerolactone Manufacturer Market Share
3.5 Global δ-Valerolactone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and δ-Valerolactone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global δ-Valerolactone Market Size by Region
4.1.1 Global δ-Valerolactone Sales in Volume by Region (2016-2026)
4.1.2 Global δ-Valerolactone Revenue by Region (2016-2026)
4.2 North America δ-Valerolactone Revenue (2016-2026)
4.3 Europe δ-Valerolactone Revenue (2016-2026)
4.4 Asia-Pacific δ-Valerolactone Revenue (2016-2026)
4.5 South America δ-Valerolactone Revenue (2016-2026)
4.6 Middle East and Africa δ-Valerolactone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global δ-Valerolactone Sales in Volume by Type (2016-2026)
5.2 Global δ-Valerolactone Revenue by Type (2016-2026)
5.3 Global δ-Valerolactone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global δ-Valerolactone Sales in Volume by Application (2016-2026)
6.2 Global δ-Valerolactone Revenue by Application (2016-2026)
6.3 Global δ-Valerolactone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America δ-Valerolactone Sales by Type (2016-2026)
7.2 North America δ-Valerolactone Sales by Application (2016-2026)
7.3 North America δ-Valerolactone Market Size by Country
7.3.1 North America δ-Valerolactone Sales in Volume by Country (2016-2026)
7.3.2 North America δ-Valerolactone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe δ-Valerolactone Sales by Type (2016-2026)
8.2 Europe δ-Valerolactone Sales by Application (2016-2026)
8.3 Europe δ-Valerolactone Market Size by Country
8.3.1 Europe δ-Valerolactone Sales in Volume by Country (2016-2026)
8.3.2 Europe δ-Valerolactone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific δ-Valerolactone Sales by Type (2016-2026)
9.2 Asia-Pacific δ-Valerolactone Sales by Application (2016-2026)
9.3 Asia-Pacific δ-Valerolactone Market Size by Region
9.3.1 Asia-Pacific δ-Valerolactone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific δ-Valerolactone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America δ-Valerolactone Sales by Type (2016-2026)
10.2 South America δ-Valerolactone Sales by Application (2016-2026)
10.3 South America δ-Valerolactone Market Size by Country
10.3.1 South America δ-Valerolactone Sales in Volume by Country (2016-2026)
10.3.2 South America δ-Valerolactone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa δ-Valerolactone Sales by Type (2016-2026)
11.2 Middle East & Africa δ-Valerolactone Sales by Application (2016-2026)
11.3 Middle East & Africa δ-Valerolactone Market Size by Country
11.3.1 Middle East & Africa δ-Valerolactone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa δ-Valerolactone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 δ-Valerolactone Typical Distributors
12.3 δ-Valerolactone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global δ-Valerolactone Revenue by Type, (USD Million), 2021-2026
Table 2. Global δ-Valerolactone Revenue by Application, (USD Million), 2021-2026
Table 3. BASF Basic Information, Manufacturing Base and Competitors
Table 4. BASF Major Business
Table 5. BASF δ-Valerolactone Product and Services
Table 6. BASF δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Ube Industries Basic Information, Manufacturing Base and Competitors
Table 8. Ube Industries Major Business
Table 9. Ube Industries δ-Valerolactone Product and Services
Table 10. Ube Industries δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. MYJ Chemical Basic Information, Manufacturing Base and Competitors
Table 12. MYJ Chemical Major Business
Table 13. MYJ Chemical δ-Valerolactone Product and Services
Table 14. MYJ Chemical δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ningbo INNO Pharmchem Basic Information, Manufacturing Base and Competitors
Table 16. Ningbo INNO Pharmchem Major Business
Table 17. Ningbo INNO Pharmchem δ-Valerolactone Product and Services
Table 18. Ningbo INNO Pharmchem δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Skylead Pharmaceuticals & Chemicals Basic Information, Manufacturing Base and Competitors
Table 20. Skylead Pharmaceuticals & Chemicals Major Business
Table 21. Skylead Pharmaceuticals & Chemicals δ-Valerolactone Product and Services
Table 22. Skylead Pharmaceuticals & Chemicals δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Penta Manufacturing Basic Information, Manufacturing Base and Competitors
Table 24. Penta Manufacturing Major Business
Table 25. Penta Manufacturing δ-Valerolactone Product and Services
Table 26. Penta Manufacturing δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Zhejiang Boadge Chemical Basic Information, Manufacturing Base and Competitors
Table 28. Zhejiang Boadge Chemical Major Business
Table 29. Zhejiang Boadge Chemical δ-Valerolactone Product and Services
Table 30. Zhejiang Boadge Chemical δ-Valerolactone Sales (MT), Price (US$/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global δ-Valerolactone Sales by Manufacturer (2019-2021e) & (MT)
Table 32. Global δ-Valerolactone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in δ-Valerolactone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global δ-Valerolactone Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and δ-Valerolactone Production Site of Key Manufacturer
Table 36. δ-Valerolactone New Entrant and Capacity Expansion Plans
Table 37. δ-Valerolactone Mergers & Acquisitions in the Past Five Years
Table 38. Global δ-Valerolactone Sales by Region (2016-2021e) & (MT)
Table 39. Global δ-Valerolactone Sales by Region (2021-2026) & (MT)
Table 40. Global δ-Valerolactone Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global δ-Valerolactone Revenue by Region (2021-2026) & (USD Million)
Table 42. Global δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 43. Global δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 44. Global δ-Valerolactone Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global δ-Valerolactone Revenue by Type (2021-2026) & (USD Million)
Table 46. Global δ-Valerolactone Price by Type (2016-2021e) & (US$/MT)
Table 47. Global δ-Valerolactone Price by Type (2021-2026) & (US$/MT)
Table 48. Global δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 49. Global δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 50. Global δ-Valerolactone Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global δ-Valerolactone Revenue by Application (2021-2026) & (USD Million)
Table 52. Global δ-Valerolactone Price by Application (2016-2021e) & (US$/MT)
Table 53. Global δ-Valerolactone Price by Application (2021-2026) & (US$/MT)
Table 54. North America δ-Valerolactone Sales by Country (2016-2021e) & (MT)
Table 55. North America δ-Valerolactone Sales by Country (2021-2026) & (MT)
Table 56. North America δ-Valerolactone Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America δ-Valerolactone Revenue by Country (2021-2026) & (USD Million)
Table 58. North America δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 59. North America δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 60. North America δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 61. North America δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 62. Europe δ-Valerolactone Sales by Country (2016-2021e) & (MT)
Table 63. Europe δ-Valerolactone Sales by Country (2021-2026) & (MT)
Table 64. Europe δ-Valerolactone Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe δ-Valerolactone Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 67. Europe δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 68. Europe δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 69. Europe δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 70. Asia-Pacific δ-Valerolactone Sales by Region (2016-2021e) & (MT)
Table 71. Asia-Pacific δ-Valerolactone Sales by Region (2021-2026) & (MT)
Table 72. Asia-Pacific δ-Valerolactone Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific δ-Valerolactone Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 75. Asia-Pacific δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 76. Asia-Pacific δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 77. Asia-Pacific δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 78. South America δ-Valerolactone Sales by Country (2016-2021e) & (MT)
Table 79. South America δ-Valerolactone Sales by Country (2021-2026) & (MT)
Table 80. South America δ-Valerolactone Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America δ-Valerolactone Revenue by Country (2021-2026) & (USD Million)
Table 82. South America δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 83. South America δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 84. South America δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 85. South America δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 86. Middle East & Africa δ-Valerolactone Sales by Country (2016-2021e) & (MT)
Table 87. Middle East & Africa δ-Valerolactone Sales by Country (2021-2026) & (MT)
Table 88. Middle East & Africa δ-Valerolactone Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa δ-Valerolactone Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa δ-Valerolactone Sales by Type (2016-2021e) & (MT)
Table 91. Middle East & Africa δ-Valerolactone Sales by Type (2021-2026) & (MT)
Table 92. Middle East & Africa δ-Valerolactone Sales by Application (2016-2021e) & (MT)
Table 93. Middle East & Africa δ-Valerolactone Sales by Application (2021-2026) & (MT)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. δ-Valerolactone Typical Distributors
Table 97. δ-Valerolactone Typical Customers
List of Figures
Figure 1. δ-Valerolactone Picture
Figure 2. Global δ-Valerolactone Sales Market Share by Type in 2020
Figure 3. Assay: 98%
Figure 4. Assay: 99%
Figure 5. Global δ-Valerolactone Sales Market Share by Application in 2020
Figure 6. Coatings, Adhesives, Resin Additives
Figure 7. Pharmaceutical and Agrochemical Intermediates
Figure 8. Global δ-Valerolactone Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 9. Global δ-Valerolactone Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global δ-Valerolactone Sales (2016-2026) & (MT)
Figure 11. Global δ-Valerolactone Price by Type (2016-2026) & (US$/MT)
Figure 12. Global δ-Valerolactone Production Capacity (2016-2026) & (MT)
Figure 13. Global δ-Valerolactone Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. δ-Valerolactone Market Drivers
Figure 15. δ-Valerolactone Market Restraints
Figure 16. δ-Valerolactone Market Trends
Figure 17. Global δ-Valerolactone Sales Market Share by Manufacturer in 2020
Figure 18. Global δ-Valerolactone Revenue Market Share by Manufacturer in 2020
Figure 19. δ-Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 δ-Valerolactone Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 δ-Valerolactone Manufacturer (Revenue) Market Share in 2020
Figure 22. Global δ-Valerolactone Sales Market Share by Region (2016-2026)
Figure 23. Global δ-Valerolactone Revenue Market Share by Region (2016-2026)
Figure 24. North America δ-Valerolactone Revenue (2016-2026) & (USD Million)
Figure 25. Europe δ-Valerolactone Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific δ-Valerolactone Revenue (2016-2026) & (USD Million)
Figure 27. South America δ-Valerolactone Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa δ-Valerolactone Revenue (2016-2026) & (USD Million)
Figure 29. Global δ-Valerolactone Sales Market Share by Type (2016-2026)
Figure 30. Global δ-Valerolactone Revenue Market Share by Type (2016-2026)
Figure 31. Global δ-Valerolactone Price by Type (2016-2026) & (US$/MT)
Figure 32. Global δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 33. Global δ-Valerolactone Revenue Market Share by Application (2016-2026)
Figure 34. Global δ-Valerolactone Price by Application (2016-2026) & (US$/MT)
Figure 35. North America δ-Valerolactone Sales Market Share by Type (2016-2026)
Figure 36. North America δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 37. North America δ-Valerolactone Sales Market Share by Country (2016-2026)
Figure 38. North America δ-Valerolactone Revenue Market Share by Country (2016-2026)
Figure 39. United States δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe δ-Valerolactone Sales Market Share by Type (2016-2026)
Figure 43. Europe δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 44. Europe δ-Valerolactone Sales Market Share by Country (2016-2026)
Figure 45. Europe δ-Valerolactone Revenue Market Share by Country (2016-2026)
Figure 46. Germany δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific δ-Valerolactone Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific δ-Valerolactone Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific δ-Valerolactone Revenue Market Share by Region (2016-2026)
Figure 55. China δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America δ-Valerolactone Sales Market Share by Type (2016-2026)
Figure 62. South America δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 63. South America δ-Valerolactone Sales Market Share by Country (2016-2026)
Figure 64. South America δ-Valerolactone Revenue Market Share by Country (2016-2026)
Figure 65. Brazil δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa δ-Valerolactone Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa δ-Valerolactone Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa δ-Valerolactone Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa δ-Valerolactone Revenue Market Share by Country (2016-2026)
Figure 71. Turkey δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa δ-Valerolactone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source